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1. Introduction 
Human lactotransferrin (also called lactoferrin) 
[l-3] consists of a single polypeptide chain of 
molecular weight 76 500 [4,5] and possesses two 
carbohydrate groups which are conjugated to the 
protein by an asparaginyl-N-acetylglucosamine linkage 
[6] : their structures were established by Spik et al. 
[7,8]. However, the present knowledge of the amino 
acid sequence of human lactotransferrin remains very 
limited: some cyanogen bromide fragments have .been 
purified and analyzed [9] and six short cysteic acid 
containing peptides [lo] as well as short tryptic and 
chymotryptic glycopeptides [7,8,1 l] have been 
sequenced. Finally glycine has been identified as the 
N-terminal amino acid [IO] . 
The present paper is dealing with the establish- 
ment of the N-terminal sequence of human lacto- 
transferrin and of the corresponding cyanogen bromide 
fragment. Extensive similarities were thus demon- 
strated between the N-terminal regions of the ovo-, 
serum- and lactotransferrins. 
2. Materials and methods 
Human lactotransferrin was obtained according to 
Cheron et al. [12] . The protein was reduced following 
the procedure of Crestfield et al. [13] ; iodoacetamide 
was employed for the alkylation step. The preparation 
and purification of the cyanogen bromide (CNBr) 
fragments were reported by Mazurier et al. [9 and 
unpublished results] . 
The N-terminal amino acids of the protein and of 
North-Holland Publishing Company -Amsterdam 
the CNBr-fragment were identified by the dansylation 
procedure. Automated Edman degradation was carried 
out in a Socosi Sequencer Model PS-100, by the 
quadrol double-cleavage method [ 141; dithioeri- 
thrytol was added in I-chlorobutane (10 mg/l). The 
thiazolinones were converted into the corresponding 
phenylthiohydantoin (PTH)-amino acids; the latter 
were characterized, as previously reported [ 151, by 
thin-layer chromatography, by gas-liquid chromato- 
graphy (Beckman GC 45 chromatograph) and by 
chromatography of the free amino acids (Technicon 
amino acid Autoanalyzer) regenerated from the PTH- 
amino acids (150°C; 24 h; 6 M HCl containing 
l/2000 2-mercaptoethanol). 
The chymotryptic digestion of CNBr-fragment 
F-V’ was performed during 24 h at 37’C in 0.05 M 
NH4HC03 with an eniymelsubstrate ratio of l/20. 
The chymotryptic peptides were purified by paper 
electrophoresis (Whatman No. 1) at pH 6.5 (pyridine- 
water-acetic acid, 100 : 900 : 4, v/v/v) and 50 V/cm. 
3. Results 
3.1. N-terminal sequence of human lactotransfem’n 
By the dansylation procedure, Gly was charac- 
terized as the N-terminal amino acid of the protein. 
By automated Edman degradation, the ten first 
amino acids could be identified (table 1). 
3.2. i%e N-terminal cyanogen bromide fragment of 
human lactotransferrin: characterization of the 
first 24 amino acids of the protein 
7 CNBr-fragments (F-I to F-VII) have so far been 
27 
Volume 69, number 1 FEBS LETTERS 
Table 1 
October 1976 
N-terminal sequences of human lactotransferrin and of the cyanogen bromide fragment F-V’ (N-terminal 
moiety of the intact lactotransferrin molecule). Methods of identification were as follows: (a) +, 
PTH-derivative determined by thin-layer chromatography; cysteine was determined as PTH-S-carbox- 
amidomethylcysteine; (b) PTH-amino acid determined by gas-liquid chromatography, yield %; (c) amino 
acid determined with an Autoanalyzer after regeneration, % of recovery. 
Human CNBr-fragment 
lactotransferrin F-V’ 
Sequence 
position a b C Residue a b C Residue 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
Gly Gly (18) 
Arg* 
A.rg* 
Arg* 
Arg* 
Ser Ser (11) 
Val Val (12) 
Gln 
Trp Trp (5) 
CYS 
GUY (20) 
Arg (4) 
Arg (4.2) 
Arg (4.8) 
Arg (4) 
val (12) 
Glu (8) 
CYS (1) 
GUY 
A% 
Arg 
Arg 
Arg 
Ser 
Val 
Gln 
Trp 
CYS 
GUY GUY (15) 
Ser 
Val 
Gln 
TIP 
CYS 
Ala 
Val 
Ser 
Gln 
Pro 
Glu 
Ala 
Thr 
LYS 
CYS 
Phe 
Gln 
Trp 
Gln 
Ser (17) 
Val (24) 
Trp (15) 
CYS 
Ala (18) 
Val (18) 
Ser (13) 
Pro (5) 
Ala (7) 
Thr 
CYS 
Phe (2) 
Trp (0.5) 
Gly (18) 
Arg (7) 
Arg (7) 
Arg (9) 
Arg (9) 
Val (19) 
Glu (14) 
CYS (2) 
Ala (14) 
Val (14) 
Glu (10) 
Pro (3) 
Glu (4) 
Ala (5) 
LYS (4) 
CYs(O.5) 
Phe (2) 
Glu (1) 
GUY 
‘4% 
Arg 
A% 
Arg 
Ser 
Val 
Gln 
TIP 
CYS 
Ala 
Val 
Ser 
Gln 
Pro 
Glu 
Ala 
Thr 
LYS 
CYS 
Phe 
Gln 
Trp 
Gln 
* Characterized by thin-layer chromatography during 3.5 h (instead of 0.5 h) in solvent 7 (15) and staining 
with the Sakaguchi reagent. 
Table 2 
Mobility m (at pH 6.5) values, yields and structures of the chymotryptic peptides of fragment F-V’ of human 
lactotransferrin. m = 0 for Gly; m = +l for Arg; m = -1 for CySO,H. 
Peptide m 
C-l + 1.15 35 
c-2 0 35 
c-3 -0.25 50 
C-4 -0.56 15 
c-5 + 0.58 32 
C-6** +0.33 34 
Yield 
(%) 
Structure 
Gly-Arg-Ag-Arg-Arg 
Ser-Val-Gln-Trp 
Cys-Ala-Val-Ser-Gln-Pro-Glu-Ala-Thr-Lys-Cys-Phe 
PyrGlu*-Trp 
Gln-(Asx, Ser, Ala, Val, Arg,)-HSer* 
Gln-Trp-Gln-(Asx, Ser, Ala, Val, Arg,)-HSer* 
* PyrGlu, pyrrolidonecarboxylic acid; HSer, homoserine. 
** C-6 = C-4 + C-5. 
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isolated [9]. During further purification of fragment 
F-V, a peptide F-V’ was obtained by filtration on 
Biogel P6 with 10% acetic acid as eluent followed by 
chromatography on Dowex 1 X 2 with a pyridine 
(IO%)-acetic acid buffer of pH 8.4. 
Its amino acid composition was established 
(residues/mole b tween parentheses): Asp (1) Thr (l), 
Ser (3), Glu (5), Pro (1) Gly (1) Ala (3) CYS (2), 
W(3), Phe (1) Trp (2) Lys (11, &I (6X H.&r (1). 
F-V’ was submitted to automated Edman degradation. 
Table 1 indicates that this fragment constitutes the 
N-terminal region of human lactotransferrin; a sequence 
constituted by the first 24 amino acids was established, 
and this result is reported for the tirst time. 
Fragment F-V’ was further submitted to a chymo- 
tryptic digestion. Table 2 indicates the mobilities, 
yields and structures of six chymotryptic peptides 
(C-l to C-6) in the order as they appear in the sequence 
Peptide C-6 was composed of peptides C-4 + C-5; in 
C-4, glutamine was characterized as pyrrolidone- 
carboxylic acid. An unusual chymotryptic split was 
observed after the fourth arginine residue of F-V’. 
The study of peptides C-l to C-6 corroborated the 
data established by automated Edman degradation. 
4. Discussion 
4.1. Comparison of the amino terminal regions of 
3 transferrins 
From the N-terminal sequence of human serum 
transferrin which we previously published [161 and 
present data concerning human lactotransferrin, the 
alignments proposed in table 3 could be constructed; 
they demonstrate strikingly the extensive similarity 
between the N-terminal regions of the two proteins. 
We point out more particularly the satisfactory 
alignment of the cysteinyl residues present in both 
sequences: this was not possible when the N-terminal 
sequence of serum transferrin proposed by Sutton 
and Brew [ 171 was considered. Our results were in 
accordance with the highly conservative behaviour of 
cysteinyl residues during evolution, a fact illustrated 
by several other published phylogenetic protein data. 
Table 3 also includes William’s recently established 
long N-terminal sequence of hen ovotransferrin 
30 
quoted, without details, by Bluard-Deconinck etal. 
[ 181 despite the fact that it differs from previously 
published ata by Elleman and Williams [191; indeed 
the N-terminal sequence of hen transferrin presents 
again a close homology with the corresponding 
sequences of the two human transferrins. 
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